Literature DB >> 11154728

Management of bleeding and coagulopathy after heart surgery.

B L Milas1, D R Jobes, R C Gorman.   

Abstract

Mechanisms of bleeding common to virtually all patients after heart surgery are platelet dysfunction, enhanced fibrinolysis, dilution of all components of the coagulation system, and the presence of heparin and protamine. The use of warfarin is increasing in patients with heart disease requiring surgery. The replenishment of vitamin K-dependent factors beyond a normal prothrombin time is not assessable, and the dilution associated with cardiopulmonary bypass can reach coagulopathic levels. Optimal preoperative preparation is required and intraoperative therapy initiated when indicated. Individualized heparin and protamine dosing, antifibrinolytic drug administration, minimization of blood loss and dilution, and minimal time on cardiopulmonary bypass are basic adjuncts to meticulous surgical hemostasis. When bleeding is observed in the postoperative period, a sequential assessment of the probable cause leads to initial therapy while laboratory test results are obtained. Ongoing assessment for hemodynamic instability caused by accumulated mediastinal blood is needed while managing the bleeding patient. A chest radiograph and transesophageal echocardiogram can be useful in diagnosing cardiac tamponade. Copyright 2000 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11154728     DOI: 10.1053/stcs.2000.20511

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  6 in total

1.  Changes in activated partial thromboplastin time and international normalised ratio after on-pump and off-pump surgical revascularization of the heart.

Authors:  Lejla Selimović Čeke; Semir Imamović; Farid Ljuca; Zoran Jerkić; Goran Imamović; Munevera Hadžimešić; Aida Pojskić; Jasmina Kovčić
Journal:  Bosn J Basic Med Sci       Date:  2014-05       Impact factor: 3.363

2.  Method to calculate the protamine dose necessary for reversal of heparin as a function of activated clotting time in patients undergoing cardiac surgery.

Authors:  Javier Suárez Cuenca; Pilar Gayoso Diz; Francisco Gude Sampedro; J Marcos Gómez Zincke; Helena Rey Acuña; M Manuela Fontanillo Fontanillo
Journal:  J Extra Corpor Technol       Date:  2013-12

3.  Re-exploration for bleeding or tamponade after cardiac operation.

Authors:  Júlia Čanádyová; Dušan Zmeko; Aleš Mokráček
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-03-20

4.  Short-term independent mortality risk factors in patients with cirrhosis undergoing cardiac surgery.

Authors:  Juan Carlos Lopez-Delgado; Francisco Esteve; Casimiro Javierre; Xose Perez; Herminia Torrado; Maria L Carrio; David Rodríguez-Castro; Elisabet Farrero; Josep Lluís Ventura
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-12-12

Review 5.  Therapeutic options to minimize allogeneic blood transfusions and their adverse effects in cardiac surgery: a systematic review.

Authors:  Antônio Alceu dos Santos; José Pedro da Silva; Luciana da Fonseca da Silva; Alexandre Gonçalves de Sousa; Raquel Ferrari Piotto; José Francisco Baumgratz
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Oct-Dec

6.  Intraoperative Use of Epsilon Amino Caproic Acid and Tranexamic Acid in Surgeries Performed Under Cardiopulmonary Bypass: a Comparative Study To Assess Their Impact On Reopening Due To Postoperative Bleeding.

Authors:  Pratiti Choudhuri; Binay Kumar Biswas
Journal:  Ethiop J Health Sci       Date:  2015-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.